Site Search

Science has tended to neglect diseases that affect small numbers of people, but that is changing.

News from IMI’s COVID-19 therapeutics projects, launched in the wake of the pandemic outbreak

Experts from the IMI Scientific Committee weigh in on what needs to happen to speed up rare disease research. In June 2020, the IMI Scientific Committee issued a set of recommendations that call for a new way to address problems in rare disease research. We asked two of the ...

The Innovative Medicines Initiative (IMI) welcomes the proposal to launch a new public-private partnership (PPP) for health under Horizon Europe, and hopes that the Innovative Health Initiative (IHI) will build on the successes and lessons learnt from IMI. Since the launch of the ...

The diagnostic projects launched by IMI in 2020 are making steady progress.

STOPFOP are trialling the cancer drug saracatinib, which has shown promise in stopping muscle and tissue from turning to bone in FOP patients

COMBACTE-NET partner Da Volterra can move forward with phase 3 trial of an innovative product used to protect the microbiome of patients from antibiotic-induced disruption

From co-design to connecting the dots, paediatric cancer needs to be integrated along the healthcare continuum

COMBACTE-MAGNET has launched a new, freely-accessible online tool that allows healthcare professionals and the public to assess the risk of international travellers acquiring (and spreading) antimicrobial-resistant bacteria